CYP2C9 and colorectal carcinoma: Secondly, the subgroup meta-analyses considering sex different between CYP2C9 polymorphisms and CRC risk, was performed on the basis of a fraction of all the possible data to be pooled, so selection bias may have occurred and our results may be overinflated.